Dipen M. Maru

15.9k citations

212 papers · 9.8k indexed · 2 hit papers · h-index 56

Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 24
Oncology top 0.2%
- Colorectal Cancer Treatments and Studies 63
- Pancreatic and Hepatic Oncology Research 22
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 21
Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes 86
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 30
Surgery
- Esophageal Cancer Research and Treatment 81
- Esophageal and GI Pathology 48

Co-authors: Scott Kopetz Jean‐Nicolas Vauthey Wayne L. Hofstetter Jaffer A. Ajani Michael J. Overman Stephen G. Swisher Cathy Eng Thomas A. Aloia
Cited by: Hepatology Oncology Cancer Research
Journals: Nature (2 papers)Nature Communications (1 paper)Journal of Clinical Oncology (40 papers)
Partner nations: United States China Japan

In The Last Decade

Dipen M. Maru

209 papers receiving 9.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Dipen M. Maru

Since Specialization

Citations

This map shows the geographic impact of Dipen M. Maru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipen M. Maru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipen M. Maru more than expected).

Fields of papers citing papers by Dipen M. Maru

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipen M. Maru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipen M. Maru. The network helps show where Dipen M. Maru may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dipen M. Maru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dipen M. Maru Line = papers co-authored together Dipen M. Maru links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid Tumors Nature Communications ·Michael LaPelusa,Wei Qiao,Bryan Iorgulescu,Francis San Lucas,Keyur Patel,Deepak Bhamidipati,Jane V. Thomas,Y. Nancy You,Wai Chin Foo,Dipen M. Maru,Selvi Thirumurthi,Van K. Morris,Scott Kopetz,Michael J. Overman,Kaysia Ludford	2025	1
2	Circulating tumor DNA as a predictive biomarker for pathologic response after treatment with neoadjuvant immunotherapy for localized dMMR/MSI-H colorectal cancer. Journal of Clinical Oncology ·Michael LaPelusa,F. Anthony San Lucas,Bryan Iorgulescu,Keyur P. Patel,Yijie You,Wai Chin Foo,Dipen M. Maru,Scott Kopetz,Kaysia Ludford,Van K. Morris,Michael J. Overman	2024	0
3	ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma The Annals of Thoracic Surgery ·Alexei A. Goltsov,Dipen M. Maru,Riham Katkhuda,Dzifa Y. Duose,Rajyalakshmi Luthra,Arlene M. Correa,Feng Wang,P. Andrew Futreal,Wayne L. Hofstetter	2023	1
4	Identification of Colorectal Cancer Cell Stemness from Single-Cell RNA Sequencing Molecular Cancer Research ·Kangyu Lin,Saikat Chowdhury,Mohammad A. Zeineddine,Fadl A. Zeineddine,Nicholas J. Hornstein,Oscar E. Villarreal,Dipen M. Maru,Cara Haymaker,Jean‐Nicolas Vauthey,George J. Chang,Elena Bogatenkova,David G. Menter,Scott Kopetz,John Paul Shen	2023	8
5	Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease JHEP Reports ·Jingjing Jiao,Jessica I. Sanchez,Ómar A. Saldarriaga,Luisa M. Solis,David J. Tweardy,Dipen M. Maru,Heather L. Stevenson,Laura Beretta	2022	31
6	ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer Clinical Cancer Research ·Amir Mehrvarz Sarshekeh,Jumanah Alshenaifi,Jason Roszik,Ganiraju C. Manyam,Shailesh Advani,Riham Katkhuda,Anuj Verma,Michael Lam,Jason Willis,John Paul Shen,Jeffrey S. Morris,Jennifer S. Davis,Jonathan M. Loree,Hey Min Lee,Jaffer A. Ajani,Dipen M. Maru,Michael J. Overman,Scott Kopetz	2021	40
7	Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? Diseases of the Esophagus ·David B. Nelson,K. G. Mitchell,Brian Weston,Sonia L. Betancourt,Dipen M. Maru,David C. Rice,Reza J. Mehran,Boris Sepesi,Mara B. Antonoff,Garrett L. Walsh,Stephen G. Swisher,Jack A. Roth,Ara A. Vaporciyan,Mariela A. Blum,Wayne L. Hofstetter	2019	15
8	Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience Diseases of the Esophagus ·K. G. Mitchell,David B. Nelson,Erin M. Corsini,Ara A. Vaporciyan,Mara B. Antonoff,Reza J. Mehran,David C. Rice,Jack A. Roth,Boris Sepesi,G. Walsh,Manisha Bhutani,Dipen M. Maru,Chen-Yu Wu,Q-N Nguyen,Jaffer A. Ajani,Stephen G. Swisher,Wayne L. Hofstetter	2019	25
9	Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes Clinical Cancer Research ·Jonathan M. Loree,Allan Andresson Lima Pereira,Michael Lam,Alexandra N. Willauer,Kanwal Raghav,Arvind Dasari,Van K. Morris,Shailesh Advani,David G. Menter,Cathy Eng,Kenna Shaw,Russell R. Broaddus,Mark J. Routbort,Yusha Liu,Jeffrey S. Morris,Rajyalakshmi Luthra,Funda Meric‐Bernstam,Michael J. Overman,Dipen M. Maru,Scott Kopetz	2017	201
10	Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancerbreakdown → Journal of Clinical Oncology ·Scott Kopetz,Jayesh Desai,Emily Chan,J. Randolph Hecht,Peter J. O’Dwyer,Dipen M. Maru,Van K. Morris,Filip Jankú,Arvind Dasari,Woonbok Chung,Jean‐Pierre J. Issa,Peter Gibbs,Brian P. James,Garth Powis,K. B. Nolop,Suman Bhattacharya,Leonard B. Saltz	2015	513
11	Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection The Annals of Thoracic Surgery ·Rajeev Dhupar,Robert D. Rice,Arlene M. Correa,Brian Weston,Manoop S. Bhutani,Dipen M. Maru,Sonia L. Betancourt,David C. Rice,Stephen G. Swisher,Wayne L. Hofstetter	2015	28
12	18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients European Journal of Cancer ·Elena Elimova,Xuemei Wang,Elba Etchebehere,Hironori Shiozaki,Yusuke Shimodaira,Roopma Wadhwa,Venkatram Planjery,Nikolaos Charalampakis,Mariela A. Blum,Wayne L. Hofstetter,Jeff H. Lee,Brian Weston,Manoop S. Bhutani,Jane E. Rogers,Dipen M. Maru,Heath D. Skinner,Homer A. Macapinlac,Jaffer A. Ajani	2015	47
13	Hippo Coactivator YAP1 Upregulates SOX9 and Endows Esophageal Cancer Cells with Stem-like Properties Cancer Research ·Shumei Song,Jaffer A. Ajani,Soichiro Honjo,Dipen M. Maru,Qiongrong Chen,Ailing W. Scott,Todd R. Heallen,Lianchun Xiao,Wayne L. Hofstetter,Brian Weston,Jeffrey H. Lee,Roopma Wadhwa,Kazuki Sudo,John R. Stroehlein,James F. Martin,Mien‐Chie Hung,Randy L. Johnson	2014	211
14	Association between KRAS mutation and lung metastasis in advanced colorectal cancer British Journal of Cancer ·Allan Andresson Lima Pereira,Juliana F. Rego,Van K. Morris,Michael J. Overman,Cathy Eng,Christopher R. Garrett,Adam T. Boutin,Renata Ferrarotto,M. Lee,Z. Jiang,Paulo M. Hoff,Jean‐Nicolas Vauthey,Eduardo Vilar,Dipen M. Maru,Scott Kopetz	2014	71
15	Loss of TGF-β Adaptor β2SP Activates Notch Signaling and SOX9 Expression in Esophageal Adenocarcinoma Cancer Research ·Shumei Song,Dipen M. Maru,Jaffer A. Ajani,Chia‐Hsin Chan,Soichiro Honjo,Hui‐Kuan Lin,Arlene M. Correa,Wayne L. Hofstetter,Marta Davila,John Stroehlein,Lopa Mishra	2013	57
16	Durable Complete Responses in Metastatic Colorectal Cancer Treated with Chemotherapy Alone Clinical Colorectal Cancer ·Renata Ferrarotto,Priyanka Pathak,Dipen M. Maru,Atin Agarwal,Michael J. Overman,Paulo M. Hoff,Scott Kopetz	2011	47
17	Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis Diseases of the Esophagus ·Yuki Hayashi,Arlene M. Correa,Wayne L. Hofstetter,Ara A. Vaporciyan,R. Mehran,David C. Rice,Akihiro Suzuki,J. H. Lee,Manisha Bhutani,James W. Welsh,S. H. Lin,Dipen M. Maru,S.G. Swisher,Jaffer A. Ajani	2011	13
18	Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome PLoS ONE ·Soo Mi Kim,Yun-Yong Park,Eun Sung Park,Y. Choi,Julie Izzo,Di Zhang,Sang-Bae Kim,Jeffrey H. Lee,Manoop S. Bhutani,Stephen G. Swisher,Xifeng Wu,Kevin R. Coombes,Dipen M. Maru,Kenneth K. Wang,Navtej Buttar,Jaffer A. Ajani,(unknown),(unknown)	2010	115
19	MicroRNA-196a Is a Potential Marker of Progression during Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus American Journal Of Pathology ·Dipen M. Maru,Rajesh R. Singh,Christina Hannah,Constance T. Albarracin,Yong X. Li,Ronald Abraham,Angela Romans,Hui Yao,Madan G. Luthra,Sharmila Anandasabapathy,Stephen G. Swisher,Wayne L. Hofstetter,Asif Rashid,Rajyalakshmi Luthra	2009	123
20	High-resolution imaging in Barrett's esophagus: a novel, low-cost endoscopic microscope Gastrointestinal Endoscopy ·Timothy J. Muldoon,Sharmila Anandasabapathy,Dipen M. Maru,Rebecca Richards‐Kortum	2008	87

About Dipen M. Maru

Dipen M. Maru is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 212 papers that have together received 9.8k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (86 papers), Esophageal Cancer Research and Treatment (81 papers), Colorectal Cancer Treatments and Studies (63 papers), Esophageal and GI Pathology (48 papers), Genetic factors in colorectal cancer (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Cancer Genomics and Diagnostics (21 papers). The work is most often cited by research in Hepatology (2.1k citations), Oncology (5.6k citations) and Cancer Research (1.8k citations). Dipen M. Maru has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Scott Kopetz, Jean‐Nicolas Vauthey, Wayne L. Hofstetter, Jaffer A. Ajani, Michael J. Overman, Stephen G. Swisher, Cathy Eng, Thomas A. Aloia, Manoop S. Bhutani and Yun Shin Chun. Their work appears in journals such as Nature, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact